Clinical Trial Update: Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy [NA]

View source ↗

Summary

Clinical trial update showing completion of a study comparing mycophenolate mofetil to intravenous cyclophosphamide pulses in crescentic IgA nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Cyclophosphamide (intravenous) (cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: IGA Nephropathy | NA | Status: COMPLETED